Working... Menu
Trial record 1 of 1 for:    GDC-0077
Previous Study | Return to List | Next Study

To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03006172
Recruitment Status : Recruiting
First Posted : December 30, 2016
Last Update Posted : June 5, 2019
Information provided by (Responsible Party):
Genentech, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 14, 2021
  Estimated Study Completion Date : December 14, 2021